Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Benjamin Lahner
Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Selin Somersan-Karakaya
Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Xuefang Wu
Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Joseph Im
Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Minji Lee
Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Bharatkumar Koyani
Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Ian Setliff
Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Malika Thakur
Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Daoyu Duan
Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Aurora Breazna
Biostatistics and Data Management, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Fang Wang
Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Gabor Halasz
Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Jacek Urbanek
Biostatistics and Data Management, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Yamini Patel
General Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Gurinder S Atwal
Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Jennifer D Hamilton
Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Samuel Stuart
Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Oren Levy
Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Andreja Avbersek
Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Rinol Alaj
Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Sara C Hamon
Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States
Gait is impaired in musculoskeletal conditions, such as knee arthropathy. Gait analysis is used in clinical practice to inform diagnosis and monitor disease progression or intervention response. However, clinical gait analysis relies on subjective visual observation of walking as objective gait analysis has not been possible within clinical settings due to the expensive equipment, large-scale facilities, and highly trained staff required. Relatively low-cost wearable digital insoles may offer a solution to these challenges. In this work, we demonstrate how a digital insole measuring osteoarthritis-specific gait signatures yields similar results to the clinical gait-lab standard. To achieve this, we constructed a machine learning model, trained on force plate data collected in participants with knee arthropathy and controls. This model was highly predictive of force plate data from a validation set (area under the receiver operating characteristics curve [auROC] = 0.86; area under the precision-recall curve [auPR] = 0.90) and of a separate, independent digital insole dataset containing control and knee osteoarthritis subjects (auROC = 0.83; auPR = 0.86). After showing that digital insole-derived gait characteristics are comparable to traditional gait measurements, we next showed that a single stride of raw sensor time-series data could be accurately assigned to each subject, highlighting that individuals using digital insoles can be identified by their gait characteristics. This work provides a framework for a promising alternative to traditional clinical gait analysis methods, adds to the growing body of knowledge regarding wearable technology analytical pipelines, and supports clinical development of at-home gait assessments, with the potential to improve the ease, frequency, and depth of patient monitoring.